Keywords: China, Pharma marker, Price controls, Reforms, Essential drug list, BMI

Dynamics of China's $47 billion pharmaceutical market have changed, says BMI

Article | 28 January 2011

Intense promotional activities by drug makers and the rapid roll-out of health insurance coverage in China have boosted Business Monitor ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in